NCT06114940 2026-03-05
PLUTO
Jinling Hospital, China
Phase 2 Terminated
Clinical Trials
4 trialsNCT06255223 2025-09-03
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Jinling Hospital, China
Phase 2 Recruiting
NCT04028245 2025-08-07
SPARC-1
Columbia University
Phase EARLY_PHASE1 Active not recruiting
NCT03991130 2025-02-06
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma
University of California, San Diego
Phase 2 Terminated